(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

Cited by (240)

Items 101–200 of 240

1. Antiviral Activities of MCC-478, a Novel and Specific Inhibitor of Hepatitis B Virus
   Naohiro Kamiya, Atsushi Kubota, Yumiko Iwase, Kouichi Sekiya, Masaru Ubasawa, Satoshi Yuasa · 2002 · Antimicrobial Agents and Chemotherapy
2. Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription
   Eric J. Arts, Mark A. Wainberg · 1994 · Antimicrobial Agents and Chemotherapy
3. Synthesis and anti-HIV activities of 2′-deoxy-2′,2″-difluoro-β-L-ribofuranosyl-pyrimidine and -purine nucleosides
   Yuejun Xiang, Lakshmi P. Kotra, Chung K. Chu, Raymond F. Schinazi · 1995 · Bioorganic & Medicinal Chemistry Letters
4. Increased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyurea
   Sarah Palmer, S. Cox · 1997 · Antimicrobial Agents and Chemotherapy
5. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
   Felipe Terra Martins, Antonio Carlos Doriguetto, Javier Ellena · 2009 · Crystal Growth & Design
6. Synthesis of novel l-N-MCd4T as a potent anti-HIV agent
   Ah‐Young Park, Hyung Ryong Moon, Kyung Ran Kim, Moon Woo Chun, Lak Shin Jeong · 2006 · Organic & Biomolecular Chemistry
7. Simultaneous determination of HIV-protease inhibitors lamivudine and zidovudine in pharmaceutical formulations by micellar electrokinetic chromatography
   Ramaiyan Sekar, Srinivasan Azhaguvel · 2005 · Journal of Pharmaceutical and Biomedical Analysis
8. Design and synthesis of a novel ring-expanded 4′-thio-apio-nucleoside derivatives
   Yuichi Yoshimura, Yoshiko Yamazaki, Masatoshi Kawahata, Kentaro Yamaguchi, Hiroki Takahata · 2007 · Tetrahedron Letters
9. Histological Improvements after a Three-Year Lamivudine Therapy in Patients with Chronic Hepatitis B in Whom YMDD Mutants Did Not or Did Develop
   Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Satoshi Saitoh, Akihito Tsubota, Fumitaka Suzuki, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Yuzo Miyakawa et al. · 2003 · Intervirology
10. Gag-Pol Supplied in trans Is Efficiently Packaged and Supports Viral Function in Human Immunodeficiency Virus Type 1
    Melissa K. Hill, C. William Hooker, David Harrich, Suzanne M. Crowe, Johnson Mak · 2001 · Journal of Virology
11. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells
    Meghan M. Carter, Salina M Torres, Dennis L. Cook, Consuelo L. McCash, Mia Yu, Vernon E. Walker, Dale M. Walker · 2007 · Environmental and Molecular Mutagenesis
12. N- and S-α-l-Arabinopyranosyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. First synthesis and biological evaluation
    Nasser S. A. M. Khalil · 2007 · European Journal of Medicinal Chemistry
13. Phosphatidyl-2′,3′-dideoxy-3′-thiacytidine: synthesis and antiviral activity in hepatitis B- and HIV-1-infected cells
    Hong Jian Xie, Michael V. Voronkov, Dennis C. Liotta, Brent A. Korba, Raymond F. Schinazi, Douglas D. Richman, Karl Y. Hostetler · 1995 · Antiviral Research
14. 3′-Azido-3′-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants
    Eric J. Arts, Miguel E. Quiñones‐Mateu, Jamie L. Albright, James-Paul Marois, Charles Hough, Zhengxian Gu, Mark A. Wainberg · 1998 · Journal of Virology
15. Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors
    Angelica C. Giuffre, Joanne Higgins, Robert W. Buckheit, Thomas W. North · 2003 · Antimicrobial Agents and Chemotherapy
16. Synthesis of optically active 2′,3′-dideoxy-3′-oxa-4′-thio-ribonucleoside analogues by transposition of a leaving group on chiral oxathiolanes via a reductive-oxidative process
    Wei Wang, Haolun Jin, Tarek S. Mansour · 1994 · Tetrahedron Letters
17. Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
    Maia Hightower, Esper Georges Kallas · 2003 · The Brazilian Journal of Infectious Diseases
18. Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1
    Louise Cooley, Joseph Sasadeusz · 2003 · Journal of Clinical Virology
19. Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
    Francis Joseph Giles, Eric Jay Feldman, Gail J. Roboz, Richard A. Larson, Steven W. Mamus, Jörge E. Cortes, Srđan Verstovšek, Stefan H Faderl, Moshe Talpaz, Miloslav Beran et al. · 2003 · Leukemia Research
20. Effect of Transport Inhibitors and Additional Anti-HIV Drugs on the Movement of Lamivudine (3TC) across the Guinea Pig Brain Barriers
    Julie Elizabeth Gibbs, T. Rashid, Sarah Ann Thomas · 2003 · Journal of Pharmacology and Experimental Therapeutics
21. Cellular metabolism in lymphocytes of a novel thioether–phospholipid–AZT conjugate with anti-HIV-1 activity
    Gregory L. Kucera, C GOFF, Nathan Iyer, Susan Lynne Morris-Natschke, Khalid S. Ishaq, Steve Wyrick, Ronald Alan Fleming, Louis S. Kucera · 2001 · Antiviral Research
22. The design and synthesis of nucleoside triphosphate isosteres as potential inhibitors of HIV reverse transcriptase
    Richard John Weaver, Ian Hugh Gilbert · 1997 · Tetrahedron
23. The transcription factor PAX5 activates human LINE1 retrotransposons to induce cellular senescence
    Huanyin Tang, Jiaqing Yang, Junhao Xu, Weina Zhang, Anke Geng, Ying Jiang, Zhiyong Mao · 2024 · EMBO Reports
24. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Anna Garbelli, Valentina Riva, Emmanuele Crespan, Giovanni Maga · 2017 · Biochemical Journal
25. Anti-HIV-1 activity and mode of action of mirror image oligodeoxynucleotide analogue of zintevir
    Hidehito Urata, Tetsuya Kumashiro, Takuya Kawahata, Toru Otake, Masao Akagi · 2003 · Biochemical and Biophysical Research Communications
26. Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2′,3′-Dideoxy-3′-Thiacytidine
    Elias Konstantine Halvas, Evguenia S. Svarovskaia, Eric O. Freed, Vinay K. Pathak · 2000 · Journal of Virology
27. Effect of Trimethoprim on the Renal Clearance of Lamivudine in Rats
    Takatoshi Takubo, Toshihiro Kato, Junji Kinami, K. Hanada, Hiroyasu Ogata · 2000 · Journal of Pharmacy and Pharmacology
28. Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk
    Seth Chekata Inzaule, Paul J. Weidle, Chunfu Yang, Kenneth Ndiege, Raph L Hamers, Tobias F. Rinke de Wit, Timothy K. Thomas, Clement E. Zeh · 2016 · Journal of Antimicrobial Chemotherapy
29. THE CHEMICAL RESOLUTION OF RACEMICCIS-2-HYDROXYMETHYL-5-(CYTOSINE-1′-YL)-1,3-OXATHIOLANE (BCH-189)—ONE DIRECT METHOD TO OBTAIN LAMIVUDINE AS ANTI-HIV AND ANTI-HBV AGENT
    Jizhen Li, Lianxun Gao, Mengxian Ding · 2002 · Synthetic Communications
30. Efficacy of Antiretroviral Agents against Murine Replication-Competent Retrovirus Infection in Human Cells
    Sharon K. Powell, Moria Artlip, Michele Kaloss, Scott Brazinski, Russette M. Lyons, Gerard J. McGarrity, Ed Otto · 1999 · Journal of Virology
31. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine
    Jennifer J. Rahn, Dawn M. Kieller, D. Lorne Tyrrell, W P Gati · 1997 · Antimicrobial Agents and Chemotherapy
32. Automated high-performance liquid chromatographic analysis of (−)-2′-deoxy-3′-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems
    Poe‐Hirr Hsyu, Thomas L. Lloyd · 1994 · Journal of Chromatography B Biomedical Sciences and Applications
33. Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of In Vitro Lamivudine Drug Pressure
    Stefano Rusconi, Maria Pia De Pasquale, Laura Milazzo, Semir Kurtagic, Elisabetta Bulgheroni, Paola Citterio, Morena Galazzi, Simona La Seta Catamancio, Massimo Galli · 1998 · Antiviral Therapy
34. Synthesis of new chiral 1,3,4-thiadiazole-based di- and tri-arylsulfonamide residues and evaluation of in vitro anti-HIV activity and cytotoxicity
    Maria Shafique, Shahid Hameed, Muhammad Moazzam Naseer, Najim Aboud Al-Masoudi · 2018 · Molecular Diversity
35. Design and Synthesis of Isonucleosides Constructed on a 2-Oxa-6-thiabicyclo[3.2.0]heptane Scaffold
    Yuichi Yoshimura, Kazuhiro Asami, Tomozumi Imamichi, Tomoko Okuda, Kimíyasu Shiraki, Hiroki Takahata · 2010 · The Journal of Organic Chemistry
36. Synthesis of acyclic bis-vinyl pyrimidines: a general route to d4T via metathesis
    D. F. Ewing, Virginie Glaçon, Grahame Mackenzie, Denis Postel, Christophe Len · 2003 · Tetrahedron
37. Enantiospecific synthesis of [(2′S, 3′S)-bis(hydroxymethyl)azetidin-1-yl] pyrimidine nucleosides as potential antiviral agents
    Fumio Hosono, Shigeru Nishiyama, Shosuke Yamamura, Takao Izawa, Kuniki Kato, Yukimasa Terada · 1994 · Tetrahedron
38. Inhibition of Hepatitis B Virus Replication by Nucleoside Enantiomers of β-2′,3′-Dideoxypurine Analogues
    Abdelaziz Elalaoui, A. Faraj, Claire Pierra, Valérie Vivet‐Boudou, R. Johnson, Christophe Mathé, Gilles Gosselin, Brent E. Korba, Jean‐Louis Imbach, Raymond F. Schinazi et al. · 1996 · Antiviral chemistry & chemotherapy
39. Convenient one-pot synthesis of thiosugars and their efficient conversion to polyoxygenated cycloalkenes
    Jingjing Zhang, Youhong Niu, Xiao‐Ping Cao, Xin‐Shan Ye · 2012 · Tetrahedron
40. Synthesis of Some New 2-α- L -Arabinopyranosyl-1,2,4-triazines as Potential Antitumor Chemotherapeutics
    Abdel Kader Mansour, Mohga M. Eid, Nasser S. A. M. Khalil · 2003 · Nucleosides Nucleotides & Nucleic Acids
41. Versatile thiosugars in medicinal chemistry
    Aparna Das, Bimal Krishna Banik · 2020 · Elsevier eBooks
42. Comparative Evaluation of Virus Transmission Inhibition by Dual-Acting Pyrimidinedione Microbicides Using the Microbicide Transmission and Sterilization Assay
    Karen M. Watson, Christa E. Buckheit, Robert W. Buckheit · 2008 · Antimicrobial Agents and Chemotherapy
43. Rapid determination of lamivudine in human plasma by high-performance liquid chromatography
    Mahmoud Reza Alebouyeh, Hossein Amini · 2014 · Journal of Chromatography B
44. Asymmetric synthesis of both enantiomers of two acyclic nucleoside analogues related to d4T and acyclovir
    David F. Ewing, Virginie Glaçon, Grahame Mackenzie, Christophe Len · 2002 · Tetrahedron Letters
45. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells
    Anita M. Schwartz, Mary Ann McCrackin, Raymond F. Schinazi, Peter B. Hill, Thomas Wilhelm Vahlenkamp, Mary B. Tompkins, Katrin Hartmann · 2014 · American Journal of Veterinary Research
46. Troxacitabine in acute leukemia
    Ronan T. Swords, Francis Joseph Giles · 2007 · Hematology
47. Recent developments in the design of antiviral agents
    John Saunders, Janet M. Cameron · 1995 · Medicinal Research Reviews
48. Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Thymidine Analog
    Elijah Paintsil, Ginger E. Dutschman, Rong Hu, Susan P. Grill, Wing Lam, Masanori Baba, Hiromichi Tanaka, Yung‐Chi Cheng · 2007 · Antimicrobial Agents and Chemotherapy
49. In vitroimmunotoxicity of ±2′-deoxy-3′-thiacytidine, a new and-HIV agent
    Gina Lisignoli, M. Monaco, Alberto Degrassi, Stefania Toneguzzi, E Ricchi, Paolo Costigliola, A. Facchini · 1993 · Clinical & Experimental Immunology
50. Design, synthesis, and biological evaluation of novel iso-d-2′,3′-dideoxy-3′-fluorothianucleoside derivatives
    Kyung Ran Kim, Hyung Ryong Moon, Ah‐Young Park, Moon Woo Chun, Lak Shin Jeong · 2006 · Bioorganic & Medicinal Chemistry
51. Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line
    Simon Leung, Reina Bendayan · 2001 · Canadian Journal of Physiology and Pharmacology
52. High-performance chromatographic assay for the sulphoxide metabolite of 2′-deoxy-3′-thiacytidine in human urine
    Robert S. Plumb, R.D.M. Gray, Andy J. Harker, Stephen G. Taylor · 1996 · Journal of Chromatography B Biomedical Sciences and Applications
53. Cytotoxicological Analysis of a gp120 Binding Aptamer with Cross-Clade Human Immunodeficiency Virus Type 1 Entry Inhibition Properties: Comparison to Conventional Antiretrovirals
    Walter Rangel Lopes de Campos, Dayaneethie Coopusamy, Lynn Morris, Bongani M. Mayosi, Makobetsa Khati · 2009 · Antimicrobial Agents and Chemotherapy
54. Anti-human immunodeficiency virus type-1 (HIV-1) and anti-hepatitis B virus (HBV) activities of (2,3-dideoxy-2-fluoro-β-L-threo-pentofuranosyl)nucleosides
    Yuejun Xiang, Sócrates C.H. Cavalcanti, Chung K. Chu, Raymond F. Schinazi, S. Balakrishna Pai, Young-Lian Zhu, Yung‐Chi Cheng · 1995 · Bioorganic & Medicinal Chemistry Letters
55. Evolution of HIV drug Resistance in Zidovudine/Zalcitabine- and Zidovudine/ Didanosine-Experienced Patients Receiving Lamivudine-Containing Combination Therapy
    Jean‐Claude Schmit, Javier Martínez‐Picado, Lı́dia Ruiz, Cristina Jural, Kristel Van Laethem, Cecilia Cabrera, Angeles Ibanez, Teresa Puig, Myriam Witvrouw, Jan Desmyter et al. · 1998 · Antiviral Therapy
56. SIMULTANEOUS SPECTROPHOTOMETRIC ESTIMATION OF LAMIVUDINE AND SILYMARIN IN MIXTURE
    Devyani Dube, S. P. Vyas, H. S. Gour Vishwavidyalaya · 2009
57. Enantiomeric d4T analogues and their structural determination
    Abdelmajid Sélouane, Claude Vaccher, Pierre Villa, Denis Postel, Christophe Len · 2002 · Tetrahedron Asymmetry
58. Synthesis, X-ray structure,in vitroHIV and kinesin Eg5 inhibition activities of new arene ruthenium complexes of pyrimidine analogs
    Wasfi A. Al‐Masoudi, Najim Aboud Al-Masoudi, B. Weibert, Rainer F. Winter · 2017 · Journal of Coordination Chemistry
59. Isothiazole Derivatives as Novel HIV Replication Inhibitors
    C.C.C Cutrı̀, Adriana Garozzo, Christophe C. Pannecouque, Angelo Castro, Francesco Guerrera, Erik De Clercq · 2004 · Antiviral chemistry & chemotherapy
60. Troxacitabine-based therapy of refractory leukemia
    Francis Joseph Giles · 2002 · Expert Review of Anticancer Therapy
61. PHARMACOLOGICAL AND BIOLOGICAL ASPECTS OF BASIC RESEARCH ON NUCLEOSIDE-BASED REVERSE TRANSCRIPTASE INHIBITORS
    Beatrice Macchi, Antonio Mastino · 2002 · Pharmacological Research
62. Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation
    Mimtsoudis, Iordanis, Tsachouridou, Olga, Akinosoglou, Karolina, Metallidis, Symeon · 2024 · Viruses
63. Lamivudine as a Nucleoside Template To Engineer DNA-Like Double-Stranded Helices in Crystals
    Alline Torquato Vasconcelos, Cameron Capeletti da Silva, Luiz Henrique Keng Queiroz Júnior, Mábio J. Santana, Vinicius Sousa Ferreira, Felipe Terra Martins · 2014 · Crystal Growth & Design
64. Synthesis of 4′-Thionucleosides as Antitumor and Antiviral Agents
    Yuichi Yoshimura, Yukako Saito, Yoshihiro Natori, Hideaki Wakamatsu · 2018 · Chemical and Pharmaceutical Bulletin
65. The Validation of a Simple, Robust, Stability-Indicating RP-HPLC Method for the Simultaneous Detection of Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir Sodium in Bulk Material and Pharmaceutical Formulations
    Omobolanle Ayoyinka Omoteso, Marnus Milne, Marique Elizabeth Aucamp · 2022 · International Journal of Analytical Chemistry
66. Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up
    Shinichi Oka, Kazuko Ikeda, Misao Takano, Miwa Ogane, Junko Tanuma, Kunihisa Tsukada, Hiroyuki Gatanaga · 2020 · Global Health & Medicine
67. Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity
    Eric J. Arts, Miguel E. Quiñones‐Mateu, Jamie L. Albright · 1998 · Drug Resistance Updates
68. Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activity of pyrimidine oxathiolane nucleosides
    Woo-Baeng Choi, Suresh N. Yeola, Dennis C. Liotta, Raymond F. Schinazi, George R. Painter, Michelle Davis, Marty St. Clair, Phillip A. Furman · 1993 · Bioorganic & Medicinal Chemistry Letters
69. Uptake of lamivudine by rat renal brush border membrane vesicles
    Takatoshi Takubo, Toshihiro Kato, Junji Kinami, K. Hanada, Hiroyasu Ogata · 2002 · Journal of Pharmacy and Pharmacology
70. The Potential of Sub-Saharan African Plants in the Management of Human Immunodeficiency Virus Infections: A Review
    Walter Chingwaru, Jerneja Vidmar, Petrina T. Kapewangolo · 2015 · Phytotherapy Research
71. A facile and effective synthesis of lamivudine 5′-diphosphate
    Béatrice Roy, Isabelle Lefèbvre, Jean-Yves Puy, Christian Périgaud · 2011 · Tetrahedron Letters
72. A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma
    Julie Marie Vose, Amit W. Panwalkar, Robert Bélanger, Bertrand Coiffier, Michele Baccarani, S. A. Gregory, Thierry T.F. Facon, Renato Fanin, Dolores M. Caballero, Dina Ben‐Yehuda et al. · 2007 · Leukemia & lymphoma/Leukemia and lymphoma
73. (1′R,2′S,5′R)‐Menthyl‐(5R)‐acetoxy‐1,3‐oxathiolan‐(2R)‐carboxylate: Synthesis and isomeric purity determination by HPLC
    M. Arshad Siddiqui, Haolun Jin, Colleen A. Evans, Marika Pasternyk Di Marco, H. L. A. TSE, Tarek S. Mansour · 1994 · Chirality
74. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses
    Teruyo Tomita, Osamu Yokosuka, Masami Tagawa, Hiromitsu Saisho, Shinobu Tamura, Ichiro Fukuda, Masao Omata · 2000 · Journal of Hepatology
75. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
    M Chang, Virendra K. Sood, D A Kloosterman, Michael J. Hauer, Paul E. Fagerness, Phillip E. Sanders, James J. Vrbanac · 1997 · PubMed
76. Stavudine plus Lamivudine in Advanced Human Immunodeficiency Virus Disease: A Short‐Term Pilot Study
    Danielle Rouleau, Brian Conway, Janet Raboud, Sandra Rae, Signe Fransen, Andrew Shillington, Carlos Zala, Michael V. O’Shaughnessy, Julio S. G. Montaner · 1997 · The Journal of Infectious Diseases
77. Participation of sulfur occurred during the Mitsunobu reaction: synthesis of novel isodideoxythionucleosides
    Lak Shin Jeong, Su Jeong Yoo, Hyung Ryong Moon, Yun Ha Kim, Moon Woo Chun · 1998 · Journal of the Chemical Society Perkin Transactions 1
78. Clinical Pharmacokinetics of Alamifovir and Its Metabolites
    Clark Chan, Eyas Abu-Raddad, Georg Golor, Hikari Watanabe, Akira Sasaki, Kwee Poo Yeo, Danny Soon, Vikram P. Sinha, Shawn D. Flanagan, Minxia Michelle He et al. · 2005 · Antimicrobial Agents and Chemotherapy
79. Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities
    Francesco Scaglione, Liberato Berrino · 2012 · International Journal of Antimicrobial Agents
80. Chapter 14. Antiviral Agents
    Joel C. Barrish, Robert Zahler · 1993 · Annual reports in medicinal chemistry
81. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
    M Chang, Virendra K. Sood, G J Wilson, D A Kloosterman, Phillip E. Sanders, Michael J. Hauer, Wei Zhang, Daniel G. Branstetter · 1997 · PubMed
82. Management of HIV-infected pregnant patients in malaria-endemic areas: Therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents
    Chukwuemeka S. Okereke · 1999 · Clinical Therapeutics
83. The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine
    Stephen A. Wring, Regina M. O'Neill, Janet L. Williams, William N. Jenner, Michael J. Daniel, Michael R.D. Gray, John J. Newman, Guy N. Wells, Derek R. Sutherland · 1994 · Journal of Pharmaceutical and Biomedical Analysis
84. A Novel Stereoselective Access to Substituted l-2-Deoxypentono-1,4-lactones and l-2-Deoxypentoses
    Dean V. Johnson, Roland C. Fischer, Herfried Griengl · 2000 · Tetrahedron
85. Decompensated Hepatitis B Virus-related Cirrhosis Successfully Treated with Lamivudine Allowing Surgery for Hepatocellular Carcinoma
    Seiji Nakanishi, Kojiro Michitaka, Teruki Miyake, Satoshi Hidaka, Itaru YOSHINO, Ichiro Konishi, Hidehito lUCHI, Norio Horiike, Morikazu Onji · 2003 · Internal Medicine
86. Asymmetric synthesis of (3S) 3-benzoyloxymethylisobenzofuranone and its 3R enantiomer as analogues of α,β-butenolides
    Christophe Len, Abdelmajid Sélouane, Asa Weiling, Fabien Coicou, Denis Postel · 2003 · Tetrahedron Letters
87. Enantiomerical excess determination, purification and biological evaluation of (3S) and (3R) α,β-butenolide analogues of isobenzofuranone
    Emmanuelle Lipka, Marie‐Pierre Vaccher, Claude Vaccher, Christophe Len · 2004 · Bioorganic & Medicinal Chemistry Letters
88. Development of a Glycosylation Reaction: A Key to Accessing Structurally Unique Nucleosides
    Yuichi Yoshimura · 2017 · Heterocycles
89. Resistance to Anti-Human Immunodeficiency Virus Therapeutic Agents
    Emilio A. Emini · 1995 · Springer eBooks
90. Troxacitabine in leukemia
    Ronan T. Swords, Effrosyni Apostolidou, Francis Joseph Giles · 2006 · Hematology
91. Simultaneous Spectrophotometric Determination of Lamivudine and Abacavir in the Mixture
    V. P. Devmurari · 2010 · Asian Journal of Research in Chemistry
92. Synthesis of enantiomerically pure d- and l-bicyclo[3.1.0]hexenyl carbanucleosides and their antiviral evaluation
    Ah‐Young Park, Won Hee Kim, Jin‐Ah Kang, Hye Jin Lee, Chong-Kyo Lee, Hyung Ryong Moon · 2011 · Bioorganic & Medicinal Chemistry
93. Increased DNA Polymerase Fidelity of the Lamivudine Resistant Variants of Human Hepatitis B Virus DNA Polymerase
    Young-Bin Hong, Yongwook Choi, Guhung Jung · 2004 · BMB Reports
94. Dolutegravir plus lamivudine for the treatment of HIV-1 infection
    Arturo Ciccullo, Gianmaria Baldin, Alberto Borghetti, Simona Di Giambenedetto · 2020 · Expert Review of Anti-infective Therapy
95. Asymmetric dihydroxylation of chiral styrene derivatives: development of an analytical strategy for the determination of the diastereomeric excess
    Serge Pilard, David Riboul, Virginie Glaçon, Nicolas Moitessier, Yves Chapleur, Denis Postel, Christophe Len · 2002 · Tetrahedron Asymmetry
96. Effect of Lamivudine on Uptake of Organic Cations by Rat Renal Brush-Border and Basolateral Membrane Vesicles
    Takatoshi Takubo, Toshihiro Kato, Junji Kinami, K. Hanada, Hiroyasu Ogata · 2000 · Journal of Pharmacy and Pharmacology
97. Synthesis and Biological Activities of 2′-Modified 4′-Thionucleosides
    Yuichi Yoshimura, Kenji Kitano, Mikari Watanabe, Hiroshi Satoh, Shinji Sakata, Shinji Miura, Noriyuki Ashida, Haruhiko Machida, Akira Matsuda · 1997 · Nucleosides and Nucleotides
98. Development of experimental and early investigational drugs for the treatment of Ebola virus infections
    Gary Wong, Xiangguo Qiu · 2015 · Expert Opinion on Investigational Drugs
99. Evaluation of Antiherpetic Compounds Using a Gastric Cancer Cell Line: Pronounced Activity of BVDU against Herpes Simplex Virus Replication
    Eiichi N. Kodama, Akira Igarashi, Shuichi Mori, K. Hashimoto, Toshimitsu Suzuki, Erik De Clercq, Shirô Shigeta · 1996 · Microbiology and Immunology
100. Reverse Transcriptase-Associated Ribonuclease H Activity as a Target for Antiviral Chemotherapy
     JW Rausch, SFJ Le Grice · 1997 · Antiviral chemistry & chemotherapy